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1. Introduction
Cancer is a class of diseases characterized by uncontrolled growth of abnormal cells of an
organism. All over the world millions of people die every year owing to one of the different
types of cancer. Unfortunately cancer chemotherapy finds a serious limitation since treatment
with drugs is followed by drug resistance in the tumorous cells and side effects (Efferth, 2005).
So researches have been directed to make chemotherapy treatment more efficient.
In the late years literature has reported the research on natural products as a good strategy to
discover new chemotherapy agents. One of the plants that have shown anticancer properties
is Artemisia annua L. (qinghao). It has the active ingredient artemisinin, which is used as
antimalarial. Artemisinin and derivatives have excellent efficacy against multidrug-resistant
strains of P. falciparum and they are very well tolerated (Price et al., 1998). Recently the
sensibility to artemisinin has been evaluated in some tumorous cells. Studies suggest that
artemisinin is more toxic to cancerous cells than to normal cells, so giving a new perspective
in cancer therapy (Lai et al, 2009).
However ... This book is on chemometrics and what has chemometrics to do with cancer
chemotherapy? Well... understanding how these two different areas can be related to one
another is the purpose of this chapter. You just must keep on reading this chapter and
you will see the many ways chemometrics can be employed to investigate the "behavior"
molecules exhibit considering anticancer activity and to make predictions about drugs that
were not tested yet. The potential application of chemometrics to analytical data arising from
problems in biology and medicine is enormous and, in fact, the applications of chemometrics
have diversified substantially over the last few years (Brereton, 2007; 2009). At the end of the
chapter you will note that, as in many areas of research, chemometrics plays an important role
in medicinal chemistry, fortunately.
Firstly it is necessary to remember that producing a drug is something that takes time and
money, so the process must be rationalized! However, in the past, drugs were discovered by
synthesizing a lot of molecules, rather without rigorous criteria, and testing experimentally all
of them to evaluate their capacity of cure of the disease or at least to control it. But in process
8
www.intechopen.com
2 Will-be-set-by-IN-TECH
of time this methodology became more and more inadequate, for the more new compounds
are studied the less a new compound may be discovered to be potent against a disease. It has
long been desired to design active structures on the basis of logic and calculations, not relying
on chance or trial-and-error (Fujita, 1995).
Nowadays, in science, there is a basic assumpion that molecular properties and structural
characteristics are closely connected to biological functions of the compounds. It is
often assumed that compounds with similar properties and structures also display similar
biological responses. Chemical structure encodes a large amount of information explaining
why a certain molecule is active, toxic or insoluble (Rajarshi, 2008). Thus to understand the
mechanism of action of a drug it is necessary to interpret the role played by its molecular and
structural properties.
In the last decades, much scientific research has focused on how to capture and convert the
information encoded in a molecular structure into one or more numbers used to establish
quantitative relationships between structures and properties, biological activities or other
experimental properties (Puzyn et al., 2010). Quantitative structure-activity relationship
(QSAR) studies have been of great value in medicinal chemistry. Statistical tools can be used
for the prediction of the biological activities of new compounds based only on the knowledge
of their chemical structures, i.e., not depending on experimental data, which are unknown.
Such a strategy gives very useful information for the understanding of the mechanisms of the
action of drugs and proposals for syntheses, in this way rationalizing drug discovery. QSAR
is alive and well (Doweyko, 2008), that is, QSAR has been used with success and so it is still
of relevance today.
Moreover advances in computation brought software that made possible to get many different
types of information (descriptors) about the molecules. Consequently data gathered through
experiments and computers can produce a huge matrix whose elements are information
related to molecules. But it seems that analyzing all them will require infinite patience!
What to do?
Chemometics has the solution!
That is true because chemometrics is the art of extracting chemically relevant information
from data produced in chemical experiments (Wold, 1995). Most people only think of statistics
when faced with a lot of quantitative information to process (Bruns et al., 2006). In this text
we show a common and efficient methodology used in medicinal chemistry to rationalize
the process of producing a new drug by employing chemometric methods. It is presented a
molecular modeling and a chemometric study of 25 artemisinins, which involves artemisinin
and derivatives (training set, Fig. 1) with different degrees of cytotoxicities against human
hepatocellular carcinoma HepG2 (Liu et al, 2005), since among the malignant tumors in the
liver, the hepatocellular carcinoma is very commom. Literature has showed the application
of the methodology here described to investigate biological properties (antimalarial and
anticancer) of artemisinin and derivatives (Barbosa et al., 2011); (Cardoso et al., 2008);
(Pinheiro et al., 2003).
2. Methodology
Any chemometric study requires data. In this study data are obtained from molecular
descriptors calculated through computation. The start point is the molecular modeling
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step, which consists on the construction of the structures and the complete optimization of
their geometries through a quantum chemistry approach implemented in computer. This
is necessary to represent molecules as real as possible and thus to compute their molecular
descriptors. The B3LYP/6-31G∗∗ method (Levine, 1991) as implemented in the Gaussian 98
program was employed (Frisch et al., 1998), considering this strategy is suitable for optimizing
well all structures since a good description of the geometrical parameters of artemisinin is
achieved.
The 25 compounds investigated include artemisinin, amides, esters, alcohols, ketones, and
five-membered ring derivatives. All compounds have been associated to their in vitro
bioactivity against a human hepatocellular carcinoma cell line, HepG2, and were labeled
previously into two classes according with their activities: (-) less active (those with IC50  97
µM) and (+) more active (those with IC50 < 97 µM) derivatives. The criteria for choosing this
value of IC50 are rather subjective. Nevertheless it is convenient to say that 97 µM is the IC50
for artemisinin and the higher IC50 the less active is the compound.
After molecular modeling, 1700 descriptors (independent variables) were computed for
each molecule in the training set. They represent different source of chemical information
(features) regarding the molecules and include geometric, electronic, quantum-chemical,
physical-chemical, topological descriptors and others. They are assumed to be important
to understand molecular characteristics such as bioactivity against cancer. In fact one of
the purposes of a research like this is to find which descriptors of the molecules are better
related to the disease under study, in this example cancer. The software used to compute
these descriptors were e-Dragon (Virtual Computational Laboratory , 2010), a product from
the Virtual Computational Laboratory and Gaussian 98 (Frisch et al., 1998).
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Fig. 1. Artemisinin and derivatives (training set) with different degrees of cytotoxicities
against human hepatocellular carcinoma HepG2
However, a crucial point to be considered in any data analysis is preprocessing. The original
data matrix usually does not have optimal value distribution for the analysis (for example
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it has different units and variances in variables), which requires some pretreatment prior
to multivariate analysis. In general, the autoscale preprocessing, which results in scaled
variables with zero mean and unit variance, is used (Ferreira, 2002). Then, all variables were
auto-scaled as a preprocessing so that they could be standardized and this way could have
the same importance regarding the scale.
Then the next step consists on application of multivariate statistical methods to find key
features involving molecules, descriptors and anticancer activity. The methods include
principal component analysis (PCA), hiererchical cluster analysis (HCA), K-nearest neighbor
method (KNN), soft independent modeling of class analogy method (SIMCA) and stepwise
discriminant analysis (SDA). The analyses were performed on a data matrix with dimension
25 lines (molecules) x 1700 columns (descriptors), not shown for convenience. For a further
study of the methodology applied there are standard books available such as (Varmuza &
Filzmoser, 2009) and (Manly, 2004).
2.1 PCA
Suppose that in your study, like in the example exhibited in this chapter, you have a large
set of data, certainly it will not be a simple task to analyze so many variables and extract
useful information from them. It would be a "revolution" in your research if you could
confidently interpret all data in a simpler way. Fortunately, with the aid of PCA technique,
this "revolution" can happen. Through PCA you can reduce the total number of variables to
a smaller set while maintaining as much of the original information as is possible. No matter
your area of research this is a great advantage.
Fig. 2. Plot of PC1-PC2 scores for artemisinin and derivates (training set) with activity
against human hepatocellular carcinoma HepG2. More active compounds displayed on the
left side (plus sign) while less active ones on the right side (minus sign)
Now considering our data matrix, PCA was employed looking for a small group of descriptors
so that they alone were responsible for classifying all 25 samples into two distinct classes:
more active and less active. Besides it is desirable to choose uncorrelated descriptors that
could be easier to interpret and analyze, trying to associate them to cytotoxicities against
human hepatocellular carcinoma HepG2.
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Furthermore, given the large quantity of multivariate data available, it was necessary to
reduce the number of variables. Thus, if two any descriptors had a high Pearson correlation
coefficient (r > 0.8), one of the two was randomly excluded from the matrix, since theoretically
they describe the same property to be modeled (biological response). Therefore it is sufficient
to use only one of them as an independent variable in a predictive model (Ferreira, 2002).
Moreover those descriptors that showed the same values for most of the samples were
eliminated too.
Compound IC5 Mor29m O1 MlogP Activity
1 4.862 -0.305 -0.246 2.845 97
2 5.253 -0.308 -0.200 2.630 >100
3 5.389 -0.372 -0.202 3.080 >100
4 5.628 -0.445 -0.194 4.845 9.5
5 5.684 -0.474 -0.205 5.250 2.8
6 5.624 -0.525 -0.214 5.644 1.2
7 5.501 -0.514 -0.211 6.027 0.46
8 5.364 -0.518 -0.191 6.400 0.79
9 5.225 -0.501 -0.210 6.765 4.2
10 5.217 -0.236 -0.205 3.036 >100
11 5.597 -0.526 -0.218 6.050 0.72
12 5.197 -0.179 -0.225 7.171 >100
13 5.253 -0.364 -0.246 3.141 >100
14 5.253 -0.322 -0.237 3.141 >100
15 5.159 -0.294 -0.259 7.095 >100
16 5.159 -0.232 -0.258 7.095 >100
17 5.180 -0.443 -0.219 2.996 >100
18 5.168 -0.307 -0.209 7.131 >100
19 5.624 -0.485 -0.186 5.644 1.8
20 5.856 -0.518 -0.218 3.941 3.5
21 5.543 -0.562 -0.344 5.449 1.3
22 5.419 -0.560 -0.320 5.837 0.77
23 5.280 -0.591 -0.281 6.215 0.74
24 5.516 -0.498 -0.269 5.855 3.7
25 5.488 -0.545 -0.273 5.815 0.47
Mean 5.378 -0.425 -0.234 5.164
Stardard Deviation 0.225 0.121 0.040 1.570
Table 1. Values of the four descriptors selected through PCA for compounds from the
training set
After this step, PCA was performed in order to continue reducing the dimensionality of the
data, find descriptors that could be useful in characterizing the behavior of the compounds
acting against cancer and look for natural clustering in the data and outlier samples. While
processing PCA, several attempts to obtain a good classification of the compounds are made.
At each attempt, one or more variables are removed, PCA is run and the score and loading
plots are analyzed.
The score plot gives information about the compounds (similarities and differences). The
loading plot gives information about the variables (how they are connected to each other and
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which are the best to describe the variance in the original data). Depending on the results
displayed by the plots, variables remain removed or included in the data matrix. If a removal
of a variable contributes to separate compounds showed by the score plot into two classes
(more and less active), then in the next attempt PCA is run without this variable. But if no
improvement is achieved, then the variable removed is inserted in the data matrix, another
variable is selected to be removed and PCA is run again. The loadings plot gives good clues
on which variables must be excluded. Variables that are very close to one another indicate
they are correlated and, as stated before, only one of them needs to remain.
This methodology comprises part of the art of variable selection: patience and intuition are
the fundamental tools here. It is not necessary to mention that the more you know about
the system you are investigating (samples and variables and how they are connected), the
more you can have success in the process of finding variables that really are important to your
investigation. Variable selection does not occur like magic, at least, not always!
The descriptors selected in PCA were IC5, Mor29m, O1 and MlogP, which represent four
distinct types of interactions related to the molecules, especially between the molecules and
the biological receptor. These descriptors are classified as steric (IC5), 3D-morse (Mor29m),
electronic (O1) and molecular (MlogP). The main properties of a drug that appear to influence
its activity are its lipophilicity, the electronic effects within the molecule and the size and shape
of the molecule (steric effects) (Gareth, 2003).
Fig. 3. Plot of the PC1-PC2 loadings for the four descriptors selected through PCA
The PCA results show the score plot (Fig. 2) relative to the first and second principal
components. In PC1, there is a distinct separation of the compounds into two classes. More
active compounds are on the left side, while less active are on the right side. They were chosen
among all data set (1700 descriptors) and they are assumed to be very important to investigate
anticancer mechanism involving artemisinins. Table 1 displays the values computed for these
four descriptors. This step was crucial since a matrix with 1700 columns was reduced to
only 4 columns. No doubt it is more appropriate to deal with a smaller matrix. The first
three principal components, PC1, PC2 and PC3 explained 43.6%, 28.7% and 20.9% of the total
variance, respectively. The Pearson correlation coefficient between the variables is in general
low (less than 0.25, in absolute values); exception occurs between Mor29m and IC5, which is
-0.65).
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Fig. 4. HCA dendogram for artemisinin and derivatives (training set) with biological activity
against human hepatocellular carcinoma HepG2. Plus sign for more active compounds while
minus sign for less active ones
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The loading plot relative to the first and second principal components can be seen in Fig. 3.
PC1 and PC2 are expressed in Equations 1 and 2, respectively, as a function of the four selected
descriptors. They represent quantitative variables that provide the overall predictive ability
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of the different sets of molecular descriptors selected. In Equation 1 the loadings of IC5 and
MlogP are negative whereas they are positive for Mor29m and O1. Among all of them IC5
and Mor29m are the most important to PC1 due to the magnitude of their coefficients (-0.613
and 0.687, respectively) in comparison to O1 and MlogP (0.234 and -0.313, respectively). For a
compound to be more active against cancer, it must generally be connected to negative values
for PC1, that is, it must present high values for IC5 and MlogP, but more negative values for
Mor29m and O1.
PC1 = −0.613IC5 + 0.687Mor29m + 0.234O1 − 0.313MlogP (1)
PC2 = −0.445IC5 + 0.081Mor29m− 0.743O1 + 0.493MlogP (2)
2.2 HCA
Considering the necessity of grouping molecules of similar kind into respective categories
(more and less active ones), HCA is suitable for this purpose since it is possible to visualize
the disposition of molecules with respect to their similarities and so make suppositions of how
they may act against the disease. When performing HCA many approaches are available.
Each one differs basically by the way samples are grouped.
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Compound K1 K2 K3 K4 K5 K6
1 - - - - - -
2 - - - - - -
3 - - - - - -
4 + + + + + +
5 + + + + + +
6 + + + + + +
7 + + + + + +
8 + + + + + +
9 + + + + + +
10 - - - - - -
11 + + + + + +
12 - - - - - -
13 - - - - - -
14 - - - - - -
15 - - - - - -
16 - - - - - -
17 - - - - - -
18 - - - - - -
19 + + + + + +
20 + + + + + +
21 + + + + + +
22 + + + + + +
23 + + + + + +
24 + + + + + +
25 + + + + + +
Table 2. Classification of compounds from the training set according to KNN method
Fig. 9. Variations in descriptors: a) Variations in IC5 for each cluster; b) Variations in Mor29m
for each cluster; c) Variations in O1 for each cluster; d) Variations in MlogP for each cluster
In this work, classification through HCA was based on the Euclidean distance and the average
group method. This method established links between samples/cluster. The distance between
two clusters was computed as the distance between the average values (the mean vector or
centroids) of the two clusters. The descriptors employed in HCA were the same selected in
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PCA, that is, IC5, Mor29m, O1 and MlogP. The representation of clustering results is shown by
the dendogram in Fig. 4, which depicts the similarity of samples. The branches on the bottom
of the dendogram represent single samples. The length of the branches linking two clusters
is related to their similarity. Long branches are related to low similarity while short branches
mean high similarity. On the scale of similarity, a value of 100 is assigned to identical samples
and a value of 0 to the most dissimilar samples. For a better interpretation of the dendogram,
the clusters are also analyzed alone (Figs. 5, 6, 7 and 8 ), and variations in descriptors in each
cluster are presented in Fig. 9. The scale above each figure is associated to the property
considered and the letters indicate the cluster in the dendogram. It is easily recognized
that descriptors in clusters in general have different pattern of variations, a characteristic
supported by the fact that clusters have different groups of molecules.
Group or class Number of Compounds Compounds wrongly classified
K1 K2 K3 K4 K5 K6
Less active 11 0 0 0 0 0 0
More active 14 0 0 0 0 0 0
%Correct information 25 100 100 100 100 100 100
Table 3. Classification matrix obtained by using KNN
The dendogram shows compounds classified into two different classes according to their
activities with no sample incorrectly classified. Less active compounds are on the left side
and are divided into clusters A (Fig. 5) and B (Fig. 6). In cluster A substituints have either
C2H5 (2, 10, 13, 14 and 17) or C4H9 (3). Here the lowest values for IC5 (Fig. 9a) and MlogP are
found (Fig. 9d). In cluster B (12, 15, 16 and 18) all substituints have C18H37 and are present the
highest values for MlogP (Fig. 9d). Considering more active samples, right side of the figure,
in cluster C (Fig. 7) compounds have amide group (exception is 11, ester, and 19, ketone) and
attached to this group there is an alkyl chain of 8 to 18 carbon atoms. Here the descriptor IC5
displays the highest values (Fig. 9a). In Cluster D (Fig. 8) substituints have an alkyl chain of
12 to 16 carbon atoms and the six-membered ring molecules with oxygen O11 are replaced by
five-membered ring molecules. Compounds display the lowest values for Mor29m (Fig. 9b)
and O1 (Fig. 9c).
Besides these two methods of classification (PCA and HCA), others (KNN, SIMCA and SDA)
were applied to data. They are important to construct reliable models useful to classify new
compounds (test set) regarding their ability to face cancer. This is certainly the ultimate
purpose of many researches in planning a new drug.
2.3 KNN
This method categorizes an unknown object based on its proximity to samples already placed
in categories. After built the model, compounds from the test set are classified and their classes
predicted taking into account the multivariate distance of the compound with respect to K
samples in the training set. The model built for KNN in this example employs leave one out
method, has 6 (six) as a maximum k value and autoscaled data. Table 2 shows classification
for each sample at each k value. Column number corresponds to k setting so that the first
column of this matrix holds the class for each training set sample when only one neighbor
(the nearest) is polled whereas the last column holds the class for the samples when the kmax
nearest neighbors are polled. Tables 2 and 3 summarizes the results for KNN analysis. All
6-nearest neighbors classified samples correctly.
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2.4 SIMCA
The SIMCA method develops principal component models for each training set category. The
main goal is the reliable classification of new samples. When a prediction is made in SIMCA,
new samples insufficiently close to the PC space of a class are considered non-members. Table
4 shows classification for compounds from the training set. Here sample 9 was classified
incorrectly since its activity is 4.2 (more active) but it is classified by SIMCA as less active.
Compound
1 2 3 4 5 6 7 8 9 10 11 12 13
Class - - - + + + + + - - + - -
Compound
14 15 16 17 18 19 20 21 22 23 24 25
Class - - - - - + + + + + + +
Table 4. Classification of compounds from the training set according to SIMCA method
Probably the reason for this misclassification lies in the fact that compound 9 may not be "well
grouped" into one of the two classes. In fact when you analyze Fig. 2 you note that 9 is the
compound classified as more active that is closer to compounds classified as less active.
Group or Class Number of Compounds True group
More active Less active
Less active 11 0 11
More active 14 14 0
Total 25
%Correct information 100 100
Table 5. Classification matrix obtained by using SDA
2.5 SDA
SDA is also a multivariate method that attempts to maximize the probability of correct
allocation. The main objectives of SDA are to separate objects from distinct populations and
to allocate new objects into populations previously defined.
The discrimination functions for less active and more active classes are, respectively,
Equations 3 and 4, given below:
YLESS = −5.728− 2.825MlogP − 0.682O1 − 3.243IC5 + 7.745Mor29m (3)
YMORE = −3.536 + 2.220MlogP + 0.536O1 + 2.548IC5− 6.086Mor29m (4)
The way the method is used is based on the following steps:
(a) Initially, for each molecule, the values for descriptors (IC5, Mor29m, O1 and MlogP) are
computed;
(b) The values from (a) are inserted in the two discrimination functions (Equation 3 and
Equation 4 ). However, since these equations were obtained from autoscaled values from
Table 1 (training set), it is necessary that values from Table 7 (test set) are autoscaled before
inserted into the equations;
195he ometric Study on Molecules with Anticancer Properties
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(c) The two values computed from (b) are compared. In case the value calculated from
Equation 3 is higher than that from Equation 4, then the molecule is classified as less active.
Otherwise, the molecule is classified as more active.
Group or Class Number of Compounds True group
More active Less active
Less active 11 0 11
More active 14 14 0
Total 25
%Correct information 100 100
Table 6. Classification matrix obtained by using SDA with Cross Validation
Through SDA all compounds of the training set were classified as presented in Table 5. The
classification error rate was 0% resulting in a satisfactory separation between more and less
active compounds.
The reliability of the model is determined by carrying out a cross-validation test, which uses
the leave-one-out technique. In this procedure, one compound is omitted of the data set and
the classification functions are built based on the remaining compounds. Afterwards, the
omitted compound is classified according to the classification functions generated. In the next
step, the omitted compound is included and a new compound is removed, and the procedure
goes on until the last compound is removed. The obtained results with the cross-validation
methodology are summarized in Table 6. Since the total of correct information was 100%, the
model can be believed as being a good model.
Compound IC5 Mor29m O1 MlogP
26 5.371 -0.437 -0.238 2.461
27 5.526 -0.544 -0.249 2.496
28 5.402 -0.516 -0.241 1.649
29 5.336 -0.481 -0.239 2.461
30 5.572 -0.553 -0.238 2.305
31 5.464 -0.411 -0.226 3.117
32 5.584 -0.323 -0.244 3.328
33 5.282 -0.496 -0.226 3.225
34 5.483 -0.570 -0.345 2.090
35 5.583 -0.667 -0.262 2.922
Table 7. Values of the four descriptors for the compounds from the test set
2.6 Classification of unknown compounds
The models built from compounds from the training set through PCA, HCA, KNN, SIMCA
and SDA now can be used to classify others compounds (test set, Fig. 10) whose anticancer
activities are unknown. So ten compounds were proposed here to verify if they must be
classified as less active or more active against a human hepatocellular carcinoma cell line,
HepG2. In fact, they were not selected from any literature, so it is supposed that they have
not been tested against this carcinoma. These compounds were selected so that they have
substituitions at the same positions as those for the training set (R1 and R2) and the same type
of atoms. It is important to keep the main characteristics of the compounds that generated
the models. This way good predictions can be achieved. The classification of the test set was
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based on the four descriptors used in the models: IC5, Mor29m, O1 and MlogP, according to
Table 7.
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Fig. 10. Compounds from the test set which must be classified as either less active or more
active
Compound PCA HCA KNN SIMCA SDA
26 - - - - -
27 + + + + +
28 - - - - -
29 - - - - -
30 + + + + +
31 - - - - -
32 - - - - -
33 - - - - -
34 + + + + +
35 + + + + +
Table 8. Predicted classification for unknown compounds from the test set through different
methods. Minus sign (-) for a compound classified as less active while plus sign (+) for a
compound classified as more active
The result presented in Table 8 reveal that all samples (test set) receive the same classification
by the four methods. Compounds 26, 28, 29, 31, 32 and 33 were classified as less active while
compounds 27, 30, 34 and 35 were classified as more active. If you look for an explanation
for such a pattern you will note that 26 and 27 present carboxylic acid group at the end of
the chain, but only 27 is classified as more active. So it is possible that the change of an ester
group by an amide group causes increase in activity. However when two amide groups are
considered as occurs in 28 and 30 more carbon atoms in substituent means more active. Now
comparing 26, 29, 31 and 32, all of them have ester group associated with another different
group and they all are classified as less active. The presence of the second group seams not to
modify activity too much. The same effect is found in 34 and 35, both more active.
3. Conclusion
All multivariate statistical methods (PCA, HCA, KNN, SIMCA and SDA) classified the 25
compounds from the training set into two distinct classes: more active and less active
according to their degree of anticancer HepG2 activity. This classification was based on IC5,
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Mor29m, O1 and MlogP descriptors. They represent four distinct classes of interactions related
to the molecules, especially between the molecules and the biological receptor: steric (IC5),
3D-morse (Mor29m), electronic (O1) and molecular (MlogP).
A test set with ten molecules with unknown anticancer activity has its molecules classified,
according to their biological response, into more active or less active compound. The results
reveal in which classes they are grouped. In general molecules classified as more active must
be seen as more efficient in cancer treatment than those classified as less active. Then the
developed studies with PCA, HCA, KNN, SIMCA and SDA can provide valuable insight
into the experimental process of syntheses and biological evaluation of the new artemisinin
derivatives with activity against cancer HepG2. Without chemometrics no model and,
consequently, no classification could be possible unless you are a prophet!
The interfacioal location of chemometrics, falling between measurements on the one side
and statistical and computational theory and methods on the other, poses a challenge to the
new practioner (Brow et al., 2009). The future of chemometrics lies in the development of
innovative solutions to interesting problems. Some of the most exciting opportunities for
innovation and new developments in the field of chemometrics lie at the interface between
chemical and biological sciences. These opportunities are made possible by the exciting new
scientific advances and discoveries of the past decade (Gemperline, 2006).
Finally, after reading this chapter you certainly must have noticed that chemometrics is a
useful tool in medicinal chemistry, mainly when the great diversity of data is taken into
account, because a lot of conclusions can be achieved. A study like this one here presented,
where different methods are employed, is one of the examples of how chemometrics is
important in drug design. Thus applications of statistics in chemical data analysis looking
for the discovery of more efficacious drugs against diseases must continue and will certainly
help researches.
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